Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients.

Abstract excerpt

INTRODUCTION: Acute kidney injury (AKI) is a common and serious complication increasing morbidity and mortality from all causes of hospital admission. We have previously shown that AKI decreases midazolam metabolism, a substrate of the cytochrome P450 3A (CYP3A) enzymes and our primary aim was to determine if this effect is dependent on the severity of AKI. We also present preliminary data on the functional...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Kidney Injury
• Share to Critical Illness
• Share to Cytochrome P-450 CYP3A